BRCA1's Role in Immune Cells and Cancer Defense
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
This project explores how changes in the BRCA1 gene affect immune cells, specifically T cells, and how this might influence the body's ability to fight breast cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11124867 on NIH RePORTER |
What this research studies
Women with BRCA1 gene mutations face a high risk of breast cancer, and current approaches mainly focus on breast tissue. However, this project looks at how the BRCA1 gene might also impact immune cells throughout the body. We are learning that BRCA1 mutations could weaken the immune system's ability to detect and eliminate cancer cells. By understanding this new role of BRCA1 in immune cells, we hope to find new ways to boost the body's natural defenses against cancer.
Who could benefit from this research
Good fit: This research is relevant for individuals, particularly women, who carry germline BRCA1 mutations and are at high risk for breast cancer.
Not a fit: Patients without BRCA1 germline mutations may not directly benefit from this specific line of research, as it focuses on the unique aspects of BRCA1-related cancer.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for preventing or treating breast cancer in individuals with BRCA1 mutations by strengthening their immune response.
How similar studies have performed: This project builds on recent preliminary findings that suggest a new role for BRCA1 in immune function, representing a novel direction in understanding BRCA1-related cancer.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Li, Rong — George Washington University
- Study coordinator: Li, Rong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.